Understanding the Barriers to Guideline Use for Depression & Anxiety in Patients with Parkinson's Disease and Dementia.
atmire.migration.oldid | 4577 | |
dc.contributor.advisor | Holroyd-Leduc, Jayna M. | |
dc.contributor.advisor | Hanson, Heather | |
dc.contributor.author | Goodarzi, Zahra | |
dc.contributor.committeemember | Jette, Nathalie | |
dc.contributor.committeemember | Patten, Scott | |
dc.contributor.committeemember | Pringsheim, Tamara | |
dc.date.accessioned | 2016-07-14T17:06:31Z | |
dc.date.available | 2016-07-14T17:06:31Z | |
dc.date.issued | 2016 | |
dc.date.submitted | 2016 | en |
dc.description.abstract | Background: Depression or anxiety are under-diagnosed and under-treated in those with dementia or Parkinson’s disease (PD). Objectives: The objectives of this thesis were to first understand what high quality guideline recommendations exist for depression or anxiety in dementia or PD. Secondly to explore the barriers and facilitators to implementing these guidelines. Methods: A systematic review of guidelines was completed, following the PRISMA statement and using the AGREE II tool to assess quality. In focus groups with stakeholders, we assessed the barriers and facilitators to guideline use and implementation. Results: Guideline quality scores were lowest for stakeholder involvement, applicability, and editorial independence. Major barriers to use included a lack of evidence, lack of applicability to the practice population, impractical or out of date recommendations. Conclusions: There are guideline recommendations for depression or anxiety in dementia and PD. However, practitioners have difficulty with implementation due to a lack of evidence and applicability. | en_US |
dc.identifier.citation | Goodarzi, Z. (2016). Understanding the Barriers to Guideline Use for Depression & Anxiety in Patients with Parkinson's Disease and Dementia. (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/28564 | en_US |
dc.identifier.doi | http://dx.doi.org/10.11575/PRISM/28564 | |
dc.identifier.uri | http://hdl.handle.net/11023/3134 | |
dc.language.iso | eng | |
dc.publisher.faculty | Graduate Studies | |
dc.publisher.institution | University of Calgary | en |
dc.publisher.place | Calgary | en |
dc.rights | University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. | |
dc.subject | Medicine and Surgery | |
dc.subject | Mental Health | |
dc.subject.classification | Parkinson's Disease | en_US |
dc.subject.classification | Dementia | en_US |
dc.subject.classification | Depression | en_US |
dc.subject.classification | anxiety | en_US |
dc.subject.classification | Clinical Practice Guidelines | en_US |
dc.title | Understanding the Barriers to Guideline Use for Depression & Anxiety in Patients with Parkinson's Disease and Dementia. | |
dc.type | master thesis | |
thesis.degree.discipline | Community Health Sciences | |
thesis.degree.grantor | University of Calgary | |
thesis.degree.name | Master of Science (MSc) | |
ucalgary.item.requestcopy | true |